For an early-stage founder, the most defensible valuation method is the one that matches what your company can actually show. Pre-revenue startups with only qualitative progress are best served by the Berkus Method or the Scorecard Method; companies with credible financial projections can use the Venture Capital Method, which works backward from a possible exit. That is the central principle that runs through expert commentary on early-stage valuation: the method should follow the startup's stage and the quality of the data available, not the other way around.

This guide covers the pre-seed to Series A range. It explains the inputs and assumptions behind the three most common methods, then provides a decision matrix that maps your stage and data type to the most appropriate approach. It does not produce a definitive valuation for any specific company, and the dollar figures described are illustrative frameworks, not market advice. Formal 409A valuations for tax and accounting purposes are a separate exercise.

The Berkus Method: Valuing Potential and Milestones

The Berkus Method estimates an early-stage startup's value by assigning dollar amounts to demonstrated progress across five factors: the idea, a prototype, the management team, strategic relationships, and product rollout or sales. Adding those amounts produces an indicative pre-money valuation — the company's value before new investment enters. Angel investor Dave Berkus developed the framework in the mid-1990s, and its starting point is evidence that the company has reduced a specific risk, rather than a detailed revenue forecast.

The mechanics are deliberately simple. Each of the five elements can receive credit of up to $500,000, and the total is often capped at $2 million pre-revenue or $2.5 million after roll-out, according to the comparison published by Equidam. Because the method prices risk reduction rather than financial performance, it fits pre-revenue companies that have milestones to point to but no meaningful metrics. Hustle Fund's analysis, written by Brian Nichols, is explicit about the method's role: it is an investor's early-stage negotiation framework, not a formal tax, accounting, or fair-value appraisal.

That framing also defines the method's limits. Once a company has revenue and operating data, the qualitative risks still matter, but the five-factor sum becomes a weaker basis for pricing, as Nichols notes. The Berkus Method answers the question "how much execution risk has this team already removed?" — a question that loses relevance as the answer becomes measurable in financial terms.

The Scorecard Method: Benchmarking Against the Market

The Scorecard Valuation Method, also known as the Bill Payne valuation method, helps angel investors value startups that can grow but have no revenue yet. It works by comparison rather than internal assessment: the target startup is benchmarked against similar funded startups on factors like stage, market, and region, using weighted percentages and market data to reach an acceptable average.

The calculation starts from the outside in. The first step, as the Angel Capital Association's methodology explains, is to determine the median pre-money valuation of pre-revenue companies in the target company's region and business sector. That median varies by geography and by the regional competitive environment for startups, though in most regions it does not differ much from one sector to another. Where local data is thin, angels can refer to recent national studies published in the association's "Angel Funders Report."

From that regional starting point, the method adjusts the median based on weighted scores across criteria such as the management team, market size, product and technology, the competitive environment, and sales channels. Equidam's comparison notes a small definitional wrinkle: Bill Payne's original method uses seven criteria, while other practitioners use six. The result has no built-in cap, unlike the Berkus Method.

The Scorecard Method's strengths and weaknesses are two sides of the same coin. A guide from Future Ventures Corp highlights that it mixes qualitative and quantitative judgment and anchors the result in real market data, but the scoring is subjective, it depends on the availability of comparable startups, and it may overvalue potential. It suits founders who can credibly argue they are stronger or weaker than the regional median on specific dimensions.

The Venture Capital Method: Focusing on Future Exit

The Venture Capital Method takes the opposite direction of travel: it works backward from a possible exit. Instead of pricing what the company has demonstrated, it starts with an assumed exit value at some future point and discounts back to what the company is worth today, given the investor's required return.

That logic makes the method more applicable to mature early-stage startups with clearer future projections, as Graphite Financial's founder's guide explains. The same guide places the Venture Capital Method alongside comparable multiples, discounted cash flow, and the First Chicago Method as tools for more mature startups, while early startups more often rely on the Berkus Method, the Scorecard Method, cost-to-duplicate, or Risk Factor Summation. The Venture Capital Method is less suitable for the earliest stages precisely because of its reliance on future exit values — a pre-revenue company with no basis for an exit assumption has nothing solid to discount.

For a founder raising a round where investors are already thinking in exit terms — typically later in the early-stage range — understanding this method matters even if the founder is not running the numbers. The investor's target return, the assumed exit multiple, and the projected financials all shape the valuation the investor will defend, and a founder who understands the mechanism can negotiate the assumptions rather than just the output.

Startup Valuation Method Decision Matrix

The matrix below maps the three methods to the two variables that matter most: where your company stands and what kind of evidence you can bring to the table. Read down the "Startup Stage" and "Primary Data Type" columns to find your situation, then check whether the method's required inputs match what you actually have.

Decision matrix: matching startup stage and data availability to valuation method
MethodStartup StagePrimary Data TypeKey Inputs and AssumptionsBest For
Berkus Method Pre-revenue only Qualitative milestones and risk reduction Dollar credit (up to $500K per element) across five factors: idea, prototype, team, strategic relationships, rollout/sales; result often capped at $2M pre-revenue, $2.5M after roll-out Founders with demonstrable progress but no financial metrics; serves as an investor's early-stage negotiation framework
Scorecard Method Pre-revenue and early stage Weighted qualitative scores plus market data Regional median pre-money valuation, adjusted by weighted scores on criteria such as management, market size, product/technology, competition, and sales channels (Payne's original: 7 criteria; some versions: 6); no built-in cap Founders who can benchmark credibly against comparable funded startups in their region and sector
Venture Capital Method Mature early-stage with clearer projections Quantitative: exit assumptions and forecasts Assumed future exit value, discounted back to today given the investor's required return Founders with defensible financial projections; less suitable for the earliest stages due to reliance on exit values

Two practical readings follow from the matrix. First, the Berkus and Scorecard Methods overlap at the pre-revenue stage but answer different questions: Berkus prices what you have already de-risked, while Scorecard prices you relative to the market. A pre-revenue founder can legitimately use both and compare results. Second, the Venture Capital Method sits at the boundary of the early-stage range — it becomes usable when your projections are credible enough that an investor would accept them as inputs, which is why Graphite Financial groups it with methods for more mature startups.

Allied Venture Partners describes this stage-matching as the essential discipline: professional investors combine qualitative assessments for pre-revenue companies with quantitative methods for more mature ones, mixing theoretical models with practical market insight. A founder who arrives at the table with the method that fits their stage signals that they understand how the other side is thinking.

Making an Informed Valuation Decision

Founders should select a valuation method that aligns with their startup's current stage and available data, and consider triangulating results from multiple methods to arrive at a defensible range. The Berkus Method gives a milestone-based floor for pre-revenue companies; the Scorecard Method tests that number against what comparable startups actually raise in your region; and the Venture Capital Method becomes relevant once your projections can carry the weight of an exit assumption.

The measurable outcome to aim for is a clear, defensible pre-money valuation range supported by the chosen method or methods and understood by potential investors. If you cannot articulate which method produced your number and why that method fits your stage, the valuation is not yet ready for a negotiation — and if an investor names a method first, the matrix above tells you what data they will ask for next.

Sources